 |
|
 |
 |
 |
 |
|
What is Essure? Leadership |
|
|
|
|
|
 Conceptus® -- a healthcare company created by a woman for women Since being founded in 1992, the objective of Conceptus® has been to provide innovative healthcare solutions for women. The driving force behind this vision is the company’s first CEO, Kathryn Tunstall. Starting as a company focused on infertility technology, Conceptus spearheaded the development of new catheter technologies for the diagnosis and treatment of blocked fallopian tubes. As Kathryn led the company through this exploration, it became clear that if it was possible to access the fallopian tubes to unblock them, it was also possible to block them. Dozens of technologies were patented and tested, including thermal energy in the tubes, but one technology -- the one that would ultimately become the Essure micro-insert -- stood out above the rest. In 1995, Conceptus re-organized and re-focused on this technology. With only $1 million available, the company set to prove the concept. Conceptus completed its initial public offering (IPO) in 1996 on the NASDAQ national stock market and traded under the ticker symbol "CPTS". In 1997, clinical testing proved the Essure procedure 99.80% effective with zero pregnancies based on four years of follow-up. The Essure® procedure was CE approved for use in Europe in 2001 and FDA approved in the United States in 2002. Mark Sieczkarek was appointed CEO in 2003 and has built on Kathryn’s vision. Mark’s outlook and perseverance has changed the way many OB/GYNs practice gynecology by pulling traditional hospital performed procedures into the office. Today, Essure is on its 3rd generation device and the procedure has 98% awareness among the OB/GYN community. Half of all Essure procedures are currently performed in the office. Conceptus continues to strive to become the preferred solution for women whose families are complete. Kathryn remains deeply involved in Conceptus in her current role as Chairwoman of the Board and her passion for improving women’s healthcare continues to grow. |
|||
|
|||
|
Site Index | Contact Us | Privacy | Consumers | Healthcare Professionals |